HIGHLIGHTS
- who: Argiris Symeonidis from the The Ohio State University, United States have published the research work: Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders, in the Journal: (JOURNAL) of December/31,/2009
- what: The addition of 2 Gy TBI over a standard treosulfan-fludarabine regimen was investigated on 51 patients Several studies aim to rationalize the therapeutic decision for allo-SCT in these diseases. The potentially ideal diagnostic and therapeutic recommendations for the four different types of myeloid neoplasia, for which this review is dedicated (CMML, aCML, JMML, and CNL), according . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.